NRSN earnings: next report 2026-09-02, real EPS beat/miss history, analyst consensus Buy, P/E -1.46. Updated 2026-07-23.
NeuroSense Therapeutics (NRSN) Research Hub
NeuroSense Therapeutics (NRSN) trades on NASDAQ, IL in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 0.3472 USD (-13.42%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.46, market cap 0.02B. This hub links to the full technical, earnings and options research available for NRSN.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, IL |
| Last close | 0.3472 USD (-13.42%) |
| 52-week range | 0.25 USD – 0.8999 USD |
| Trend regime | Range |
| 14-day RSI | 33.4 (Bearish) |
| Trailing P/E | -1.46 |
| Market cap | 0.02B |
| Dividend yield | 0.00% |
| Next earnings | 2026-09-02 |
Available research for NRSN
Covered Call on NRSN: how it works, illustrative setup around the real 0.3472 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on NRSN: how it works, illustrative setup around the real 0.3472 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on NRSN: how it works, illustrative setup around the real 0.3472 USD price, max profit/loss, breakeven and when to use it. Educational.
NRSN technical analysis: range, last 0.3472 USD, RSI 33.4, 52w range 0.25 USD–0.8999 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is NRSN in?
NeuroSense Therapeutics (NRSN) is classified under Healthcare (Biotechnology), listed on NASDAQ, IL.
Is NRSN in an uptrend or downtrend?
As of 2026-09-11, NRSN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is NRSN's trailing P/E ratio?
NRSN's trailing P/E is -1.46, with a market cap of 0.02B. See the earnings research page for full valuation detail.
When does NRSN next report earnings?
NRSN is next scheduled to report earnings on 2026-09-02, with a consensus EPS estimate of -0.195 USD.